Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer

BACKGROUND: National guidelines recommend trastuzumab for treatment of patients with metastatic HER2-positive gastric cancer (GC). There is currently no guideline indicating the number of biopsy specimens and the location from which they should be obtained to reliably determine the human epidermal g...

Descripción completa

Detalles Bibliográficos
Autores principales: Tominaga, Naoyuki, Gotoda, Takuji, Hara, Megumi, Hale, Matthew D., Tsuchiya, Takayoshi, Matsubayashi, Jun, Kono, Shin, Kusano, Chika, Itoi, Takao, Fujimoto, Kazuma, Moriyasu, Fuminori, Grabsch, Heike I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824804/
https://www.ncbi.nlm.nih.gov/pubmed/25987463
http://dx.doi.org/10.1007/s10120-015-0502-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824804/
https://www.ncbi.nlm.nih.gov/pubmed/25987463
http://dx.doi.org/10.1007/s10120-015-0502-3

Ejemplares similares